Skip to main content

KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  246.29
+4.73 (1.96%)
AAPL  259.04
-1.29 (-0.50%)
AMD  204.68
-5.34 (-2.54%)
BAC  56.18
+0.54 (0.97%)
GOOG  326.01
+3.58 (1.11%)
META  646.06
-2.63 (-0.41%)
MSFT  478.11
-5.36 (-1.11%)
NVDA  185.04
-4.07 (-2.15%)
ORCL  189.65
-3.19 (-1.65%)
TSLA  435.80
+4.39 (1.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.